SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-063618
Filing Date
2017-10-25
Accepted
2017-10-25 06:04:00
Documents
69
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20633_110q.htm 10-Q 1352922
2 EX-31.1 a17-20633_1ex31d1.htm EX-31.1 14650
3 EX-31.2 a17-20633_1ex31d2.htm EX-31.2 14468
4 EX-32.1 a17-20633_1ex32d1.htm EX-32.1 8473
5 EX-32.2 a17-20633_1ex32d2.htm EX-32.2 8452
  Complete submission text file 0001104659-17-063618.txt   6780124

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT uthr-20170930.xml EX-101.INS 1573471
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20170930.xsd EX-101.SCH 55704
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20170930_cal.xml EX-101.CAL 64743
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20170930_def.xml EX-101.DEF 240222
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT uthr-20170930_lab.xml EX-101.LAB 524372
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20170930_pre.xml EX-101.PRE 387185
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 171151989
SIC: 2834 Pharmaceutical Preparations